Analgesics: Page 15

UF provides pediatric dental sedation training

By DrBicuspid.com staff writers

The University of Florida (UF) College of Dentistry in Gainesville is helping pediatric dentists get specialized training in dental sedation and office emergency preparedness.

May 22, 2013

Study: 10% to 20% benzocaine effective for acute toothaches

By Rob Goszkowski

Benzocaine has been commonly used for pain relief for more than a century, but data about its effectiveness for relieving toothache pain have long been lacking. A new study in the Journal of the American Dental Association that examined the effectiveness of 10% and 20% benzocaine for treating toothaches yielded some interesting results.

May 12, 2013

Is ortho treatment OK in low-risk bisphosphonate patients?

By Rabia Mughal

Bisphosphonate-related osteonecrosis of the jaw has been a topic of much debate in dentistry, and now a new study has found that while orthodontic tooth movement under bisphosphonate medication is possible, especially in low-risk patients, the treatment is still not predictable.

April 28, 2013

Study: Nitrous oxide doesn't up surgical risks

By DrBicuspid.com staff writers

Giving nitrous oxide as part of general anesthesia for noncardiac surgery doesn't increase the rate of complications and death, and might even decrease the risk of such events, according to a pair of new studies.

April 23, 2013

Aspirin can help battle head/neck cancer

By Donna Domino

Aspirin appears to offer significant protection against head and neck (HNC) cancer, according to a study in the British Journal of Cancer. Regular aspirin use was associated with a 22% reduction in HNC and seems to be particularly effective in preventing laryngeal cancer.

April 11, 2013

More dental hygienists administering local anesthesia

By Rosemary Frei, MSc

A handful of U.S. states -- primarily in the south -- still do not allow dental hygienists to administer local anesthesia. But the landscape is slowly shifting, according to Tricia Osuna, RDH, who gave a talk on the subject at the recent Pacific Dental Conference.

April 9, 2013

Study: Propofol abuse by healthcare professionals rising

By DrBicuspid.com staff writers

Abuse of propofol is a "rapidly progressive form of substance dependence" that is being more commonly seen among healthcare professionals, according to a study to be published in the April 2013 Journal of Addiction Medicine.

March 19, 2013

Mannitol makes dental anesthesia more effective

By DrBicuspid.com staff writers

Combining mannitol with lidocaine significantly increases the effectiveness of an inferior alveolar nerve block, according to a new study in Anesthesia Progress.

March 18, 2013

Novartis loses another bisphosphonate/ONJ trial

By DrBicuspid.com staff writers

Novartis Pharmaceuticals, makers of the osteoporosis bisphosphonate Zometa, has been ordered to pay a Florida man $250,000 for injuries he suffered after taking Zometa to help treat his multiple myeloma.

March 18, 2013

Study questions costs of routine dental antibiotic prophylaxis

By Donna Domino

Routine antibiotic prophylaxis for dental patients who may be at risk of infection from invasive dental procedures costs the U.S. healthcare system more than $150 million annually, according to a new study in Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology. But there is little scientific basis for antibiotic prophylaxis prior to dental procedures, the authors contend.

March 17, 2013

FDA issues azithromycin warning

By DrBicuspid.com staff writers

The U.S. Food and Drug Administration (FDA) has issued a warning that the antibiotic azithromycin can cause abnormal changes in the electrical activity of the heart that may lead to a potentially fatal irregular heart rhythm.

March 13, 2013

NY woman awarded $285K in Fosamax osteonecrosis trial

By Kathy Kincade

A 69-year-old New York woman has succeeded in her efforts to hold Merck, makers of the osteoporosis drug Fosamax, accountable for her osteonecrosis of the jaw (ONJ) and related health issues. This is only the second of seven Fosamax/ONJ lawsuits in which Merck has not triumphed.

February 13, 2013

Previous Page

Page 15 of 43

Next Page